Home
Continuing Education
IMPACT Live
MPN TV Network
Ask the Experts
MPN TV Clinical Insights
Allied Health
Login
|
Register
MPN TV – Clinical Insights
MPN Clinical Insights is a way to learn and interact with your peers. These programs consist of various clinical discussions done in a round table format. Please submit a question regarding the current video playing (“Ask the Experts”) to the interviewed author(s) to learn more information regarding these panel discussions. For more information on other tumor types please check out our partner site
O
ncology
.TV
.
(www.oncology.tv)
Please select a video from the list below.
Loss of Response While Being Treated with a JAK Inhibitor
Dr. Srdan Verstovsek; Dr. Ramon V. Tiu; Dr. Ruben A. Mesa; Dr. Olatoyosi Odenike; Dr. Josef T. Prchal discuss Loss of Response in patients being treated with a JAK Inhibitor. How do you define "Loss of Response"? If you suspect "Loss of Response" what further testing should you conduct? How do you manage patients with a "Loss of Response"?
List of Questions Asked
Ask the Experts
Use the space below to submit your questions to the MPNUniversity.TV Experts. (Login required.)
Question:
Email Address:
Please wait....Submitting your Question!
MPN Highlights - ASH 2017
Views - 72
Single-Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High-Risk Polycythemia Vera (PV)...
Views - 48
The Impact of Phlebotomy and Hydroxyurea on Survival and Risk of Thrombosis among Older Patients with Polycythemia Vera
Views - 114
Validation of the Myelofibrosis Secondary to PV and ET – Prognostic Model in Patients with Post-Polycythemia Vera and Post-Essential Thrombocythemia..
Views - 21
Characteristics of Patients with Chronic Phase Myelofibrosis and Elevated Blasts (5-9%), and the Effect of JAK2 Inhibitor Ruxolitinib
Views - 38
Myelofibrosis (MF) Leukemic Transformation (LT) in the Era of Ruxolitinib and Genomics: Characteristics and Outcomes
Views - 71
Changing Patterns, and Clinical Correlates, of Mutations in Patients with Myelofibrosis over Treatment with Ruxolitinib or Hydroxyurea
Views - 13
Examining the Treatment Patterns and Blood Counts Among Patients with Polycythemia Vera Treated With Hydroxyurea in the United States: an Analysis...
Views - 22
Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis From the REVEAL Study
Views - 17
Sotatercept (ACE-011) Alone and with Ruxolitinib in Patients with MPN-associated Myelofibrosis (MF) and Anemia with Ruxolitinib or Hydroxyurea
Views - 46
Phase I/II Trial of Glasdegib in Patients With Primary or Secondary Myelofibrosis
Views - 368
Phase 3 Trial of Momelotinib versus Best Available Therapy in Patients with Myelofibrosis Previously Treated with Ruxolitinib
Views - 82
Phase 3 Trial of Momelotinib versus Ruxolitinib in JAK Inhibitor Naive Patients with Myelofibrosis
Views - 255
Mechanisms of Resistance to 5-Azacytidine/Decitabine in MDS-AML and Pre-Clinical In Vivo Proof of Principle of Rational Solutions to Extend Response
Views - 85
Radioactive Iodine Treatment of Thyroid Cancer and Risk of Myelodysplastic Syndromes
Views - 604
PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks
Views - 919
A Phase II Study of the Combination of Oral Rigosertib and Azacitidine in Patients with MDS
Views - 653
HRQoL and Efficacy with Myelofibrosis Patients in the Phase III Persist-1 Trial of Pacritinib Vs BAT
Views - 62
Quizartinib Significantly Improves Overall Survival in FLT3-ITD Positive AML Patients Relapsed after Stem Cell
Views - 232
First Multicenter, Randomized Phase 3 Study in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Alisertib Versus Investigator's Choice
Views - 71
MPNUniversity.tv is a member of the
Oncology.TV
family of oncology medical education websites. MPNUniversity.tv offers specialists, primary care physicians, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including
interactive
case based presentations), news and information about Myeloproliferative Neoplasms (MPNs).
Privacy Statement
|
Terms Of Use
|
Contact MPNUniversity.tv
|
Copyright 2019 by MPNUniversity.tv Corporation